Gaviscon Advance Oral Suspension Sodium alginate 500 mg, Potassium hydrogen carbonate 100 mg.

Licence status
Authorised: 14/08/1998
Active substances
Sodium alginate, Potassium hydrogen carbonate
Dosage Form
Oral suspension
Licence number
PA0979/011/001
Licence holder
Reckitt Benckiser Ireland Ltd

Product documents

Licence information

ATC code
A02BX Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
Legal supply status
Product not subject to medical prescription
Place of sale
Supply through pharmacies only
Marketing availability
Marketed
Advertising conditions
Advertising to the general public
Licence issued
14/08/1998